Literature DB >> 27614114

Widespread white matter and conduction defects in PSEN1-related spastic paraparesis.

Steffan K Soosman1, Nelly Joseph-Mathurin2, Meredith N Braskie3, Yvette M Bordelon4, David Wharton5, Maria Casado5, Giovanni Coppola6, Holly McCallum3, Marc Nuwer4, Pedro Coutin-Churchman4, Liana G Apostolova7, Tammie Benzinger2, John M Ringman8.   

Abstract

The mechanisms underlying presenilin 1 (PSEN1) mutation-associated spastic paraparesis (SP) are not clear. We compared diffusion and volumetric magnetic resonance measures between 3 persons with SP associated with the A431E mutation and 7 symptomatic persons with PSEN1 mutations without SP matched for symptom duration. We performed amyloid imaging and central motor and somatosensory conduction studies in 1 subject with SP. We found decreases in fractional anisotropy and increases in mean diffusivity in widespread white-matter areas including the corpus callosum, occipital, parietal, and frontal lobes in PSEN1 mutation carriers with SP. Volumetric measures were not different, and amyloid imaging showed low signal in sensorimotor cortex and other areas in a single subject with SP. Electrophysiological studies demonstrated both slowed motor and sensory conduction in the lower extremities in this same subject. Our results suggest that SP in carriers of the A431E PSEN1 mutation is a manifestation of widespread white-matter abnormalities not confined to the corticospinal tract that is at most indirectly related to the mutation's effect on amyloid precursor protein processing and amyloid deposition.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diffusion tensor imaging; Electrophysiology; PSEN1; White matter; spastic paraparesis

Mesh:

Substances:

Year:  2016        PMID: 27614114      PMCID: PMC5075491          DOI: 10.1016/j.neurobiolaging.2016.07.030

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  54 in total

1.  Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation.

Authors:  John M Ringman; Karen H Gylys; Luis D Medina; Michelle Fox; Vladimir Kepe; Deborah L Flores; Liana G Apostolova; Jorge R Barrio; Gary Small; Daniel H Silverman; Erin Siu; Stephen Cederbaum; Silva Hecimovic; Martina Malnar; Suma Chakraverty; Alison M Goate; Thomas D Bird; James B Leverenz
Journal:  Neurosci Lett       Date:  2010-11-19       Impact factor: 3.046

2.  PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease.

Authors:  J Koivunen; A Verkkoniemi; S Aalto; A Paetau; J-P Ahonen; M Viitanen; K Någren; J Rokka; M Haaparanta; H Kalimo; J O Rinne
Journal:  Brain       Date:  2008-06-25       Impact factor: 13.501

3.  Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis.

Authors:  Chul Hyoung Lyoo; Hanna Cho; Jae Yong Choi; Mi Song Hwang; Sang Kyoon Hong; Yun Joong Kim; Young Hoon Ryu; Myung Sik Lee
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

4.  2015 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2015-03       Impact factor: 21.566

5.  Presenilin 1 Met146Leu variant due to an A --> T transversion in an early-onset familial Alzheimer's disease pedigree from Argentina.

Authors:  L Morelli; M I Prat; E Levy; C A Mangone; E M Castaño
Journal:  Clin Genet       Date:  1998-06       Impact factor: 4.438

6.  Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.

Authors:  Alex E Roher; Chera L Maarouf; Michael Malek-Ahmadi; Jeffrey Wilson; Tyler A Kokjohn; Ian D Daugs; Charisse M Whiteside; Walter M Kalback; Mimi P Macias; Sandra A Jacobson; Marwan N Sabbagh; Bernardino Ghetti; Thomas G Beach
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

Review 7.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

8.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

9.  A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging.

Authors:  Jeremy A Miller; Michael C Oldham; Daniel H Geschwind
Journal:  J Neurosci       Date:  2008-02-06       Impact factor: 6.167

10.  Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities.

Authors:  S O'Riordan; P McMonagle; J C Janssen; N C Fox; M Farrell; J Collinge; M N Rossor; M Hutchinson
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910

View more
  5 in total

1.  The Whole Exome Sequencing Clarifies the Genotype- Phenotype Correlations in Patients with Early-Onset Dementia.

Authors:  Yangqi Xu; Xiaoli Liu; Junyi Shen; Wotu Tian; Rong Fang; Binyin Li; Jianfang Ma; Li Cao; Shengdi Chen; Guanjun Li; Huidong Tang
Journal:  Aging Dis       Date:  2018-08-01       Impact factor: 6.745

2.  Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease.

Authors:  Nelly Joseph-Mathurin; Guoqiao Wang; Kejal Kantarci; Clifford R Jack; Eric McDade; Jason Hassenstab; Tyler M Blazey; Brian A Gordon; Yi Su; Gengsheng Chen; Parinaz Massoumzadeh; Russ C Hornbeck; Ricardo F Allegri; Beau M Ances; Sarah B Berman; Adam M Brickman; William S Brooks; David M Cash; Jasmeer P Chhatwal; Helena C Chui; Stephen Correia; Carlos Cruchaga; Martin R Farlow; Nick C Fox; Michael Fulham; Bernardino Ghetti; Neill R Graff-Radford; Keith A Johnson; Celeste M Karch; Christoph Laske; Athene K W Lee; Johannes Levin; Colin L Masters; James M Noble; Antoinette O'Connor; Richard J Perrin; Gregory M Preboske; John M Ringman; Christopher C Rowe; Stephen Salloway; Andrew J Saykin; Peter R Schofield; Hiroyuki Shimada; Mikio Shoji; Kazushi Suzuki; Victor L Villemagne; Chengjie Xiong; Igor Yakushev; John C Morris; Randall J Bateman; Tammie L S Benzinger
Journal:  Neurology       Date:  2021-01-25       Impact factor: 9.910

3.  Spastic paraplegia preceding PSEN1-related familial Alzheimer's disease.

Authors:  Viorica Chelban; Marianthi Breza; Maria Szaruga; Jana Vandrovcova; David Murphy; Chia-Ju Lee; Sondos Alikhwan; Thomas Bourinaris; George Vavougios; Muhammad Ilyas; Sobia Ahsan Halim; Ahmed Al-Harrasi; Chrisoula Kartanou; Coras Ronald; Ingmar Blumcke; Athanasia Alexoudi; Stylianos Gatzonis; Leonidas Stefanis; Georgia Karadima; Nicholas W Wood; Lucía Chávez-Gutiérrez; John Hardy; Henry Houlden; Georgios Koutsis
Journal:  Alzheimers Dement (Amst)       Date:  2021-05-02

4.  PSEN1 c.1292C<A Variant and Early-Onset Alzheimer's Disease: A Scoping Review.

Authors:  Maribel Orozco-Barajas; Yulisa Oropeza-Ruvalcaba; Alejandro A Canales-Aguirre; Victor J Sánchez-González
Journal:  Front Aging Neurosci       Date:  2022-07-22       Impact factor: 5.702

5.  Abnormal retinal capillary blood flow in autosomal dominant Alzheimer's disease.

Authors:  Maxwell B Singer; John M Ringman; Zhongdi Chu; Xiao Zhou; Xuejuan Jiang; Anoush Shahidzadeh; Ruikang K Wang; Amir H Kashani
Journal:  Alzheimers Dement (Amst)       Date:  2021-03-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.